Latest news
An AI Drug Company Named a Candidate for Dry Macular Degeneration, and the Target Is Undisclosed - Medical DailyMedical Daily · Fri, 07 Aug 2026 11:40:26 GMTAXPAXLI Shows 72% Reduction in Injection Burden vs Aflibercept in Wet AMD - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 04 Aug 2026 06:43:26 GMTOCUL Stock In Spotlight After Q2 Loss Comes In Narrower Than Estimated – A Look At Key Highlights - TradingViewTradingView · Mon, 03 Aug 2026 12:48:47 GMTWet AMD Drug Secures First FDA-Approved Bevacizumab Status - Streetwise ReportsStreetwise Reports · Fri, 31 Jul 2026 10:37:41 GMTOutlook Therapeutics (OTLK) Is Down 24.3% After Landmark FDA Wet AMD Drug Approval - Has The Bull Case Changed? - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTFDA Approves First Ophthalmic Treatment for Wet AMD Leading Wainwright to Triple Price Target - Streetwise ReportsStreetwise Reports · Wed, 29 Jul 2026 07:00:00 GMTCHMP Backs Roche’s Susvimo for Wet AMD, European Commission Decision Pending - Eyewire+Eyewire+ · Tue, 28 Jul 2026 18:13:12 GMTAn Eye Drug Used Off-Label for Two Decades Now Has Formal Approval for Wet Macular Degeneration - Medical DailyMedical Daily · Tue, 28 Jul 2026 07:00:00 GMT